Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial	Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, angiomatosis, benign urinary system neoplasm, capillary hemangioma, carcinoma, cardiovascular disorder, endolymphatic sac tumor, epithelial neoplasm, hemangioblastoma, hemangioma, hereditary disease, kidney cancer, kidney disorder, neoplasm, nervous system disorder, neurocutaneous syndrome, neuroendocrine neoplasm, neuroepithelial neoplasm, paraganglioma, pheochromocytoma, pheochromocytoma-paraganglioma, primitive neuroectodermal tumor, renal cell carcinoma, urinary system disorder, vascular cancer, vascular disorder, von Hippel-Lindau disease	Recruiting	Phase 2	2025-09-11		NCT07167329

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AC Camargo Cancer Center	12
José Claudio Casali da Rocha	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AC Camargo Cancer Center	São Paulo	Brazil	1